Dear Colleagues,

Lung cancer is a considerable morphological complexity that is divided into small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC). In solid tumors, molecular targeting and immunotherapy for lung cancer are relatively successful. However, the treatment of patients requires comprehensive molecular diagnosis. The prediction, treatment, and prognosis of lung cancer sometimes involve highly sensitive diagnostic materials and technologies, which bring new challenges to the molecular pathology of lung cancer.

I cordially invite authors to submit original research and review articles to this Special Issue, which addresses the latest progress in and current understanding of the molecular pathology, diagnosis, and treatment of lung cancer.

The topics of this Special Issue include, but are not limited to:

• Molecular targeted therapy of lung cancer, immune checkpoint inhibitors, and neoadjuvant chemotherapy.
• Molecular analysis and characterization of lung cancer/lung tissue.
• Molecular analysis of biomarkers of acquired resistance to specific drugs for lung cancer.

Dr. Letizia Gnetti
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• lung cancer
• small-cell lung cancer
• non-small-cell lung cancer
• molecular targeting
• immunotherapy
• molecular analysis